Brief: Auris Medical Starts Preparations For Covid-19 Trial With Bentrio In India
June 1 (Reuters) - Auris Medical Holding Ltd EARS.O :
* AURIS MEDICAL STARTS PREPARATIONS FOR COVID-19 TRIAL WITH
BENTRIO IN INDIA
* AURIS MEDICAL HOLDING - STUDY WILL EVALUATE EFFICACY OF
BENTRIOTM IN PREVENTION AND TREATMENT OF ACUTE COVID-19 AND
SHALL START RECRUITMENT IN Q3 2021
Source text for Eikon: ID:nGNX5db0jB
Further company coverage: EARS.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Altamira Therapeutics
See all newsBrief: Altamira Therapeutics Reports Full Year 2024 Results
Brief: Altamira Therapeutics Announces Transition From Nasdaq To OTC Markets
Brief: Altamira Therapeutics Provides Update On Nasdaq Listing
Brief: Altamira Therapeutics Provides Business Update And First Half 2024 Financial Results
Brief: Altamira Therapeutics Announces Pricing Of Up To $12.0 Mln Public Offering